Oncolytics Biotech Inc. Files February 2025 6-K Report
Ticker: ONCY · Form: 6-K · Filed: Feb 19, 2025 · CIK: 1129928
Sentiment: neutral
Topics: foreign-private-issuer, sec-filing, routine-update
Related Tickers: ONCY
TL;DR
ONCOLYTICS BIOTECH (ONCY) filed its Feb 2025 6-K, standard foreign private issuer update.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on February 19, 2025, reporting for the month of February 2025. The company is a foreign private issuer based in Calgary, Alberta, Canada, and its principal executive offices are located at Suite 804, 322 11th Avenue SW, T2R 0C5. Oncolytics Biotech Inc. operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding the company's status and operations as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information that would inherently increase risk.
Key Players & Entities
- Oncolytics Biotech Inc. (company) — Registrant
- February 2025 (date) — Reporting period
- Calgary, Alberta, Canada (location) — Company domicile
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.
What is the filing date of this Form 6-K?
This Form 6-K was filed on February 19, 2025.
Where is Oncolytics Biotech Inc. headquartered?
Oncolytics Biotech Inc. is headquartered in Calgary, Alberta, Canada, with its principal executive offices at Suite 804, 322 11th Avenue SW, T2R 0C5.
Does Oncolytics Biotech Inc. file an annual report on Form 20-F or 40-F?
Oncolytics Biotech Inc. indicates it files its annual reports under cover of Form 20-F.
What industry does Oncolytics Biotech Inc. operate in?
Oncolytics Biotech Inc. operates in the Pharmaceutical Preparations industry, classified under SIC code 2834.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 19, 2025 regarding ONCOLYTICS BIOTECH INC (ONCY).